Top Markets
#1 Black Phoenix Black Phoenix +167.53%
#2 Islamic Coin Islamic Coin +158.30%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.49%
#5 Test Test +23.70%
#6 Cryptopia Cryptopia +20.92%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.98%
#9 Steem Steem +13.65%
#10 MarsCoin MarsCoin +9.72%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Classement en actions #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Prix de l'action
$0.0005
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$16.73K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange ARYx Therapeutics, Inc. (ARYX)

Catégorie

Healthcare
Le prix ARYX avec la capitalisation boursière de B
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
ARYX
$0.0005
Capitalisation boursière de ARYx Therapeutics, Inc.(ARYX)
Capitalisation boursière: $16.73K
En August 2026, ARYx Therapeutics, Inc. a une capitalisation boursière de $16.73K. Cela fait de ARYx Therapeutics, Inc. la 41544th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de ARYx Therapeutics, Inc. du 2007 au 2026
ARYX par rapport au top 5 des plus populaires stocks
Prix pour ARYX L’actif B La capitalisation boursière de B Résultats
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$160,880 $16.73K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +32,175,957,463.80%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$132,191 $16.73K
Apple Inc. Apple Inc.
AAPL
$4.423T +26,438,295,302.18%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$124,331 $16.73K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +24,866,232,636.13%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$109,477 $16.73K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +21,895,408,644.25%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$86,403.35 $16.73K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +17,280,669,288.56%